Patents Examined by Michael Barker
  • Patent number: 11999746
    Abstract: The present invention relates to novel compounds that inhibit Lp-PLA2 activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases associated with the activity of Lp-PLA2, for example Alzheimer's disease.
    Type: Grant
    Filed: July 29, 2019
    Date of Patent: June 4, 2024
    Assignee: GlaxoSmithKline Intellectual Property Development Limited
    Inventors: Zehong Wan, Xiaomin Zhang, Jian Wang, Matthew Robert Sender, Eric Steven Manas, Raphael Anthony Rivero, Joseph E Pero, Christopher Ernst Neipp, Vipulkumar Kantibhai Patel
  • Patent number: 11998632
    Abstract: Self-emulsifying drug delivery systems are provided for oral delivery of cannabinoids. The cannabinoids are dissolved in an oily medium (e.g. medium chain triglycerides) together with at least one surfactant to improve dissolution, stability, and bioavailability. Also provided are methods comprising uses of an oral cannabinoid compositions for the treatment of neuropathic pain in a subject.
    Type: Grant
    Filed: September 4, 2020
    Date of Patent: June 4, 2024
    Assignee: Avicanna Inc.
    Inventors: Frantz Henri Emmanuel Le Devedec, Aras Azadian, Setu Nimish Purohit, Justin Michael Grant, Samantha Carolyn Watt
  • Patent number: 11992015
    Abstract: The present invention relates to the fields of malaria and dengue virus. More specifically, the present invention provides compositions and methods useful for the treatment and prevention of malaria and dengue virus. In particular embodiments, a composition comprises mosquito nectar feed and Chromobacterium sp_Panamam (Csp_P).
    Type: Grant
    Filed: July 29, 2021
    Date of Patent: May 28, 2024
    Assignee: The Johns Hopkins University
    Inventors: George Dimopoulos, Sarah M. Short, Jose L. Ramirez
  • Patent number: 11986005
    Abstract: Methods to produce cannabis-related products derived from a cannabis oil extract subjected to a two-step supercritical carbon dioxide separation process are described. Cannabis terpenes are separated from cannabis plant material at a relatively lower temperature and pressure than the cannabis oil which may then be distilled and/or mixed with an ingredient to produce a multifunctional composition. Methods to produce medicinal and recreational cannabis and insect-related products are described.
    Type: Grant
    Filed: December 29, 2019
    Date of Patent: May 21, 2024
    Assignee: INSECTERGY, LLC
    Inventor: Daniel Michael Leo
  • Patent number: 11976065
    Abstract: The invention relates to novel crystalline forms of imiquimod formed with ferulic acid, acetic acid, coumaric acid, citric acid, or tartaric acid, to methods of making these cocrystals, and to compositions containing the cocrystals.
    Type: Grant
    Filed: June 23, 2021
    Date of Patent: May 7, 2024
    Assignee: CELISTA PHARM ACEUTICALS LLC
    Inventor: Yogesh Dandiker
  • Patent number: 11969454
    Abstract: The present invention relates to compositions comprising one or more extracts and/or compounds having retinol-like activity and properties and methods of using the compositions to treat the eye.
    Type: Grant
    Filed: November 16, 2020
    Date of Patent: April 30, 2024
    Assignee: Johnson & Johnson Surgical Vision, Inc.
    Inventors: Wen-Hwa Ting Li, Khalid Mahmood, Ramine Parsa, Mingqi Bai, Kenneth T. Holeva
  • Patent number: 11969451
    Abstract: The present invention relates to compositions comprising one or more compounds and/or extracts which induce, promote and/or improve production/release/delivery/excretion of hyaluronic acid and/or mucin from and/or in the cornea, and methods of using the compositions to treat the eye.
    Type: Grant
    Filed: November 16, 2020
    Date of Patent: April 30, 2024
    Assignee: Johnson & Johnson Surgical Vision, Inc.
    Inventors: Wen-Hwa Ting Li, Khalid Mahmood, Ramine Parsa, Manpreet Randhawa, Mingqi Bai, Kenneth T. Holeva
  • Patent number: 11964938
    Abstract: A compound of the formula (I) wherein R represents a straight or branched, primary or secondary acyclic hydrocarbyl C3-C15 group, which can be saturated or unsaturated, or a straight or branched, primary or secondary acyclic hydrocarbyl C3-C15 group, which can be saturated or unsaturated and wherein one or more of hydrogen atoms is replaced with fluorine atom; X represents hydrogen atom or halogen atom, and * denotes chiral center, and salts thereof. The compound is useful for the treatment of diseases mediated by GPR40, in particular type II diabetes.
    Type: Grant
    Filed: January 7, 2019
    Date of Patent: April 23, 2024
    Assignee: CELON PHARMA S.A.
    Inventors: Mateusz Mach, Radoslaw Dzida, Damian Smuga, Filip Stelmach, Mikolaj Matloka, Katarzyna Bazydlo, Krzysztof Dubiel, Maciej Wieczorek, Jerzy Pieczykolan
  • Patent number: 11958806
    Abstract: An object is to provide a method for easily producing maleimide (MI) in which trace amounts of residual acid components as impurities in a crude MI are efficiently reduced, that is, the acid value is sufficiently reduced. <1> A method for producing purified MI, comprising reducing an acid value of crude MI by 50% or more, by adding carbodiimide (CDI) to a solution comprising the crude MI to react an acid component in the crude MI with the CDI. <2> The method for producing purified MI, comprising adding 0.5% by mass or more and 8% by mass or less of the CDI with respect to a mass of the crude MI for reaction. <3> The method for producing purified MI, wherein the CDI is N,N?-diisopropyl carbodiimide (DIC). <4> The method for producing purified MI, comprising removing a urea derivative of the CDI (CDI-U) by-produced when reacting the acid component in the crude MI with the CDI.
    Type: Grant
    Filed: September 29, 2020
    Date of Patent: April 16, 2024
    Assignee: UNITIKA LTD.
    Inventors: Yuki Yamada, Tatsuya Morikita, Yosuke Sugimoto, Takeshi Yoshida, Akira Shigeta, Yoshiaki Echigo
  • Patent number: 11952383
    Abstract: The present subject matter involves novel tetracyclic aza-podophyllotoxin analogue compounds, a method of synthesizing said compounds, a pharmaceutical composition comprising said compounds and a suitable carrier, and a method of using the compounds. The tetracyclic aza-podophyllotoxin analogue compounds are useful as antitumor agents.
    Type: Grant
    Filed: June 30, 2023
    Date of Patent: April 9, 2024
    Assignee: KING FAISAL UNIVERSITY
    Inventors: Christophe Tratrat, Michelyne Haroun
  • Patent number: 11951143
    Abstract: Use of an olive oil milling by-product (Alperujo or Olive Pomace) for the co-processing and co-extraction of natural compounds from medicinal and aromatic plants including cannabis, fruits and agricultural waste, algae and other microorganisms. Separation and stabilization of fractions containing either hydrophilic or liposoluble compounds.
    Type: Grant
    Filed: May 20, 2021
    Date of Patent: April 9, 2024
    Inventors: Roberto Crea, Paolo Pontoniere
  • Patent number: 11951100
    Abstract: Provided herein are heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds that are useful for the treatment of retinal binding protein (RBP4) related diseases, such as macular degeneration and the like.
    Type: Grant
    Filed: September 1, 2023
    Date of Patent: April 9, 2024
    Assignee: Belite Bio, LLC
    Inventors: Yu-Hsin Tom Lin, Cheng-Chi Irene Wang
  • Patent number: 11944599
    Abstract: A method of extracting myricetin from Xanthoceras sorbifolia Bunge is provided. The method includes: step 1, baking obtaining Xanthoceras sorbifolia Bunge crude powder; step 2, mixing the crude powder with a counter-current extraction solution to perform a counter-current extraction to obtain a filtrate and a filter residue; step 3, mixing the filter residue with a solvent to obtain a first mixture, and heating the first mixture to reflux for extraction to obtain an extraction liquid; step 4, mixing the extraction liquid and the filtrate, and concentrating under reduced pressure to obtain a concentrated solution; and step 5, separating and eluting the concentrated solution to obtain an eluent, then drying the eluent to obtain the myricetin.
    Type: Grant
    Filed: September 29, 2023
    Date of Patent: April 2, 2024
    Assignee: HEBEI RUILONG BIOTECHNOLOGY CO., LTD
    Inventors: Weijia Li, Jingmei Zheng, Jingyi Yan, Junhua Wang
  • Patent number: 11938119
    Abstract: A vertically-integrated cannabis-related product production method is described, the method comprises, producing a distilled cannabinoid and/or a crystallized cannabinoid from cannabis plants, comprising: in a farming system, growing the cannabis plants, the cannabis plants comprise a cannabinoid; in an extraction system, extracting the cannabinoid from the cannabis plants; in a purification system, purifying the cannabinoid to produce a purified cannabinoid; and in a distillation and/or a crystallization system, distilling and/or crystallizing the purified cannabinoid to produce the distilled cannabinoid and/or the crystallized cannabinoid. Various ways to purify, distill, and process the cannabinoids are described. An insect pest management system may be integrated with the farming system to grow the cannabis plants in the presence of predatory mites which feed on insects and/or spider mites.
    Type: Grant
    Filed: March 17, 2021
    Date of Patent: March 26, 2024
    Assignee: INSECTERGY, LLC
    Inventor: Daniel Michael Leo
  • Patent number: 11939281
    Abstract: The present invention relates to a process for the purification of hydrogen cyanide, comprising the steps of a) splitting a liquid feed stream (1) comprising hydrogen cyanide into at least a first liquid stream (2) and a second liquid stream (3), b) introducing the first liquid stream (2) into a distillation column (4) at a point between the top and the bottom of the distillation column, c) introducing the second liquid stream (3) into the distillation column (4) at the top of the distillation column, d) withdrawing an overhead vapor stream (5) enriched in hydrogen cyanide from the distillation column (4), and e), withdrawing a bottom stream (6) depleted in hydrogen cyanide, wherein the temperature of the second liquid stream (3) in step c) is lower than the temperature of the first liquid stream (2) in step b).
    Type: Grant
    Filed: July 17, 2019
    Date of Patent: March 26, 2024
    Assignee: Evonik Operations GmbH
    Inventors: Martin Körfer, Michael Eicker, Catrin Dorothee Becker, Thorsten Merker, Marko Bussmann
  • Patent number: 11939330
    Abstract: Novel pyrido[3,4-b]indole-6-carboxylic acid compounds, a method of synthesizing said compounds, a pharmaceutical composition comprising said compounds and a suitable carrier, and a method of using the compounds. The pyrido[3,4-b]indole-6-carboxylic acid compounds, identified as CK2 inhibitors, are useful as anticancer and/or antitumor agents, and as agents for treating other kinase-associated conditions including inflammation, pain, and certain immunological disorders, and other types of diseases such as diabetes, viral infection, neurodegenerative diseases.
    Type: Grant
    Filed: August 25, 2023
    Date of Patent: March 26, 2024
    Assignee: KING FAISAL UNIVERSITY
    Inventors: Christophe Tratrat, Michelyne Haroun
  • Patent number: 11932616
    Abstract: The invention is directed to a process for the ring-opening of a cycloadduct obtainable from a reaction of a furanic compound and a diene, said process comprising contacting the cycloadduct with an acidic mixture comprising sulfuric acid and an activating agent to obtain a ring-opened product. The present invention is particularly directed a continuous process.
    Type: Grant
    Filed: April 30, 2019
    Date of Patent: March 19, 2024
    Assignee: Nederlandse Organisatie voor toegepast-natuurwetenschappelijk onderzoek TNO
    Inventors: Marc Crockatt, Johan Urbanus
  • Patent number: 11926606
    Abstract: Methods of isolating tocopherol from Commiphora myrrha using a non-polar solvent are provided.
    Type: Grant
    Filed: August 10, 2023
    Date of Patent: March 12, 2024
    Assignee: KING FAISAL UNIVERSITY
    Inventors: Amel Yousif Ahmed Ibrahim, Abdalla Ahmed Elbashir
  • Patent number: 11926639
    Abstract: A process for preparing oligo ethylene glycol methyl ether borate involves feeding boric acid and oligo ethylene glycol monomethyl ether into a reactor, and reacting to obtain a raw product containing oligo ethylene glycol methyl ether borate, water, and unreacted boric acid and oligo ethylene glycol monomethyl ether. The raw product is fed to a reactive distillation device and boric acid is reacted with oligo ethylene glycmonomethyl ether for full conversion of boric acid. A distillate stream containing water is transferred from the top of the reactive distillation device to a condenser, and a condensed liquid stream is recycled to the top of the reactive distillation device. A bottom product stream containing oligo ethylene glycol methyl ether borate is withdrawn from the reactive distillation device. The bottom product stream is partially recycled to a reboiler. The resulting vapor stream is recycled to the bottom of the reactive distillation device.
    Type: Grant
    Filed: November 19, 2020
    Date of Patent: March 12, 2024
    Assignee: BASF SE
    Inventors: Kathrin Luise Mariethres Werth, Thomas Holtmann, Rainer Papp, Mirko Haider, Joachim Wulff-Doering
  • Patent number: 11918620
    Abstract: A traditional Chinese medicine composition, and preparation method, and application thereof. The traditional Chinese medicine composition includes the following raw medicines in parts by weight: 10-35 parts of root of Chinese thorowax, 5-25 parts of immature bitter orange, 3-20 parts of fresh root and rhizome of sorrel rhubarb, 3-20 parts of root of baikal skullcap, 3-20 parts of white peony root, 3-15 parts of dried ginger, 5-20 parts of leech, 3-20 parts of root of ural licorice, 3-20 parts of root pilose asiabell, 3-20 parts of rhizome of largehead atractylodes, and 3-25 parts of tuber of pinellia. The traditional Chinese medicine composition has excellent effects in lowering blood lipids and cholesterol levels, particularly in lowering blood triglyceride. The traditional Chinese medicine composition also has excellent effects in slowing formation of atherosclerotic plaques, clearing the atherosclerotic plaques, and preventing and treating atherosclerosis.
    Type: Grant
    Filed: January 20, 2021
    Date of Patent: March 5, 2024
    Assignee: Suzhou Regen-PharmaTech Co., Ltd.
    Inventors: Be Xie, Xuefeng Ren